MedAssets (MDAS) Reports In-Line Q4 EPS, FY15 EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink Swann Downgrades MedAssets (MDAS) to Market Perform
February 18, 2015 7:24 AM ESTLeerink Swann downgraded MedAssets (NASDAQ: MDAS) from Outperform to Market Perform with a price target of $18.00 (from $26.00).
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $19.83 yesterday.
... MoreDeutsche Bank Downgrades MedAssets (MDAS) to Hold
February 18, 2015 6:47 AM ESTDeutsche Bank downgraded MedAssets (NASDAQ: MDAS) from Buy to Hold with a price target of $19.00 (from $23.00). The change follows Q4 results and guidance.
Analyst George Hill said, "MedAssets pre-announced its Q4 results and gave F2015 guidance a week ahead of schedule. Adjusted... More
